Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas

被引:36
作者
Abe, Masanobu
Westermann, Frank
Nakagawara, Akira
Takato, Tsuyoshi
Schwab, Manfred
Ushijima, Toshikazu
机构
[1] Univ Tokyo, Grad Sch Med, Natl Canc Ctr,Chuo Ku, Inst Res,Carcinogenesis Div, Tokyo 1040045, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Tokyo 1040045, Japan
[3] German Canc Res Ctr, Div Tumor Genet, D-6900 Heidelberg, Germany
[4] Chiba Canc Ctr, Inst Res, Div Biochem, Chiba, Japan
关键词
neuroblastoma; methylation; CIMP; MS-RDA; n-myc;
D O I
10.1016/j.canlet.2006.05.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The CpG island methylator phenotype (ClMP) was closely associated with poor overall survival (OS) in Japanese neuroblastoma (NBL) cases in our previous study. Here, in German NBL cases, CIMP(+) cases (n = 95) showed markedly poorer OS (hazard ratio (HR) = 9.5; P < 0.0001) and disease-free survival (DFS) (HR = 5.4; P < 0.0001) than CIMP(-) cases (n = 50). All the 23 cases with N-myc amplification had CIMP. Among the remaining cases without N-myc amplification, CIMP(+) cases (n 27) had a poorer OS (HR = 4.5; P = 0.02) and DFS (HR = 5.2; P < 0.0001) than CIMP(-) cases (n = 95). In multivariate analysis, CIMP and N-myc amplification had an influence on OS and DFS independent of age and disease stage. CIMP had a stronger influence on DFS than N-myc amplification while N-myc had a stronger influence on OS. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 17 条
[1]  
Abe M, 2005, CANCER RES, V65, P828
[2]   EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma [J].
Alaminos, M ;
Dávalos, V ;
Ropero, S ;
Setién, F ;
Paz, MF ;
Herranz, M ;
Fraga, MF ;
Mora, J ;
Cheung, NKV ;
Gerald, WL ;
Esteller, M .
CANCER RESEARCH, 2005, 65 (07) :2565-2571
[3]   Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma [J].
Alaminos, M ;
Davalos, V ;
Cheung, NKV ;
Gerald, WL ;
Esteller, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (16) :1208-1219
[4]   Neuroblastoma: Biological insights into a clinical enigma [J].
Brodeur, GM .
NATURE REVIEWS CANCER, 2003, 3 (03) :203-216
[5]   Decreased expression of the seven ARP2/3 complex genes in human gastric cancers [J].
Kaneda, A ;
Kaminishi, M ;
Sugimura, T ;
Ushijima, T .
CANCER LETTERS, 2004, 212 (02) :203-210
[6]   Methylation-sensitive representational difference analysis and its application to cancer research [J].
Kaneda, A ;
Takai, D ;
Kaminishi, M ;
Okochi, E ;
Ushijima, T .
EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT, 2003, 983 :131-141
[7]  
KANEKO Y, 1987, CANCER RES, V47, P311
[8]   The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives [J].
London, WB ;
Boni, L ;
Simon, T ;
Berthold, F ;
Twist, C ;
Schmidt, ML ;
Castleberry, RP ;
Matthay, KK ;
Cohn, SL ;
De Bernardi, B .
CANCER LETTERS, 2005, 228 (1-2) :257-266
[9]   Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification [J].
Misawa, A ;
Inoue, J ;
Sugino, Y ;
Hosoi, H ;
Sugimoto, T ;
Hosoda, F ;
Ohki, N ;
Imoto, I ;
Inazawa, J .
CANCER RESEARCH, 2005, 65 (22) :10233-10242
[10]   ASSOCIATION BETWEEN HIGH-LEVELS OF EXPRESSION OF THE TRK GENE AND FAVORABLE OUTCOME IN HUMAN NEUROBLASTOMA [J].
NAKAGAWARA, A ;
ARIMANAKAGAWARA, M ;
SCAVARDA, NJ ;
AZAR, CG ;
CANTOR, AB ;
BRODEUR, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (12) :847-854